Coloplast A/S - Deci
Coloplast A/S - Decisions at the Annual General Meeting 2023
07 déc. 2023 11h23 HE | Coloplast A/S
Today, 7 December 2023, Cololast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2022/23 was approved.Distribution...
Coloplast A/S - Indk
Coloplast A/S - Indkaldelse til ordinær generalforsamling 2023
14 nov. 2023 05h05 HE | Coloplast A/S
Den ordinære generalforsamling i Coloplast A/S afholdes torsdag den 7. december 2023 kl. 15:30 på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk,...
Coloplast A/S - Noti
Coloplast A/S - Notice of Annual General Meeting 2023
14 nov. 2023 05h05 HE | Coloplast A/S
The Annual General Meeting of Coloplast A/S will be held on Thursday, 7 December 2023 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen...
Coloplast vil åbne n
Coloplast vil åbne ny fabrik i Portugal
09 nov. 2023 01h39 HE | Coloplast A/S
Coloplast investerer omkring 700 millioner kroner i en ny fabrik i Portugal for at understøtte selskabets fortsatte vækst. Fabrikken skal producere Coloplasts engangskatetre til blandt andre...
Coloplast announces
Coloplast announces new manufacturing site in Portugal
09 nov. 2023 01h39 HE | Coloplast A/S
Coloplast, a leading company within intimate healthcare, will invest around 100 million euros in a new manufacturing site in Portugal to support the company’s continued growth.  The new...
Coloplast A/S - Årsr
Coloplast A/S - Årsrapport 2022/23 & Vederlagsrapport 2022/23
09 nov. 2023 01h32 HE | Coloplast A/S
Organisk vækst på 8% og en overskudsgrad på 28% i regnskabsåret 2022/231). Den rapporterede omsætning målt i danske kroner voksede 9% til 24.500 mio. kr. Den organiske vækst pr. forretningsområde...
Coloplast A/S - Annu
Coloplast A/S - Annual Report 2022/23 & Remuneration Report 2022/23
09 nov. 2023 01h32 HE | Coloplast A/S
FY 2022/23 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK grew 9% to DKK 24,500 million Organic growth rates by business area: Ostomy Care 8%, Continence Care 7%, Voice and...
Coloplast A/S - Årsr
Coloplast A/S - Årsregnskabsmeddelelse 2022/23
09 nov. 2023 01h32 HE | Coloplast A/S
Årsregnskabsmeddelelse(1. oktober 2022 – 30. september 2023)  Coloplast leverede en organisk vækst på 8% og en overskudsgrad på 28% i fjerde kvartal1). Den rapporterede omsætning målt i...
Coloplast A/S - Full
Coloplast A/S - Full-Year Financial Results 2022/23
09 nov. 2023 01h32 HE | Coloplast A/S
Announcement of Full-year Financial Results 2022/23(1 October 2022 - 30 September 2023) Coloplast delivered Q4 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK grew 3% to...
Coloplast A/S - FY 2
Coloplast A/S - FY 2023/24 Financial Guidance
09 nov. 2023 01h30 HE | Coloplast A/S
Coloplast announces financial guidance for the 2023/24 financial year. Organic revenue growth is expected around 8% and the EBIT margin is expected at 27-28%. The assumptions on the financial guidance...